PK-sensitive PrP Is Infectious and Shares Basic Structural Features with PK-resistant PrP
One of the main characteristics of the transmissible isoform of the prion protein (PrPSc) is its partial resistance to proteinase K (PK) digestion. Diagnosis of prion disease typically relies upon immunodetection of PK-digested PrPSc following Western blot or ELISA. More recently, researchers determined that there is a sizeable fraction of PrPSc that is sensitive to PK hydrolysis (sPrPSc). Our group has previously reported a method to isolate this fraction by centrifugation and showed that it has protein misfolding cyclic amplification (PMCA) converting activity. We compared the infectivity of the sPrPSc versus the PK-resistant (rPrPSc) fractions of PrPSc and analyzed the biochemical characteristics of these fractions under conditions of limited proteolysis. Our results show that sPrPSc and rPrPSc fractions have comparable degrees of infectivity and that although they contain different sized multimers, these multimers share similar structural properties. Furthermore, the PK-sensitive fractions of two hamster strains, 263K and Drowsy (Dy), showed strain-dependent differences in the ratios of the sPrPSc to the rPrPSc forms of PrPSc. Although the sPrPSc and rPrPSc fractions have different resistance to PK-digestion, and have previously been shown to sediment differently, and have a different distribution of multimers, they share a common structure and phenotype.
Vyšlo v časopise:
PK-sensitive PrP Is Infectious and Shares Basic Structural Features with PK-resistant PrP. PLoS Pathog 8(3): e32767. doi:10.1371/journal.ppat.1002547
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.ppat.1002547
Souhrn
One of the main characteristics of the transmissible isoform of the prion protein (PrPSc) is its partial resistance to proteinase K (PK) digestion. Diagnosis of prion disease typically relies upon immunodetection of PK-digested PrPSc following Western blot or ELISA. More recently, researchers determined that there is a sizeable fraction of PrPSc that is sensitive to PK hydrolysis (sPrPSc). Our group has previously reported a method to isolate this fraction by centrifugation and showed that it has protein misfolding cyclic amplification (PMCA) converting activity. We compared the infectivity of the sPrPSc versus the PK-resistant (rPrPSc) fractions of PrPSc and analyzed the biochemical characteristics of these fractions under conditions of limited proteolysis. Our results show that sPrPSc and rPrPSc fractions have comparable degrees of infectivity and that although they contain different sized multimers, these multimers share similar structural properties. Furthermore, the PK-sensitive fractions of two hamster strains, 263K and Drowsy (Dy), showed strain-dependent differences in the ratios of the sPrPSc to the rPrPSc forms of PrPSc. Although the sPrPSc and rPrPSc fractions have different resistance to PK-digestion, and have previously been shown to sediment differently, and have a different distribution of multimers, they share a common structure and phenotype.
Zdroje
1. PrusinerSB 1982 Novel proteinaceous infectious particles cause scrapie. Science 216 136 144
2. PrusinerSB 1998 Prions. Proc Natl Acad Sci U S A 95 13363 13383
3. DetwilerLABaylisM 2003 The epidemiology of scrapie. Rev Sci Tech 22 121 143
4. HarmanJLSilvaCJ 2009 Bovine spongiform encephalopathy. J Am Vet Med Assoc 234 59 72
5. WilliamsES 2005 Chronic wasting disease. Vet Pathol 42 530 549
6. CaugheyBWDongABhatKSErnstDHayesSF 1991 Secondary structure analysis of the scrapie-associated protein PrP 27–30 in water by infrared spectroscopy. Biochemistry 30 7672 7680
7. BaronGSHughsonAGRaymondGJOfferdahlDKBartonKA 2011 Effect of glycans and the glycophosphatidylinositol anchor on strain dependent conformations of scrapie prion protein: improved purifications and infrared spectra. Biochemistry 50 4479 4490
8. AlperTHaigDAClarkeMC 1966 The exceptionally small size of the scrapie agent. Biochem Biophys Res Commun 22 278 284
9. Bellinger-KawaharaCGKempnerEGrothDGabizonRPrusinerSB 1988 Scrapie prion liposomes and rods exhibit target sizes of 55,000 Da. Virology 164 537 541
10. RiesnerD 2003 Biochemistry and structure of PrP(C) and PrP(Sc). Br Med Bull 66 21 33
11. StahlNBaldwinMATeplowDBHoodLGibsonBW 1993 Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32 1991 2002
12. StahlNBaldwinMTeplowDBHoodLEBeavisR 1992 Cataloging post-translational modifications of the scrapie prion protein by mass spectrometry. PrusinerSBCollingeJPowellJAndertonB Prion diseases of humans and animals New York Ellis Horwood 361 379
13. RuddPMEndoTColominasCGrothDWheelerSF 1999 Glycosylation differences between the normal and pathogenic prion protein isoforms. Proc Natl Acad Sci U S A 96 13044 13049
14. SafarJWilleHItriVGrothDSerbanH 1998 Eight prion strains have PrP(Sc) molecules with different conformations. Nat Med 4 1157 1165
15. TzabanSFriedlanderGSchonbergerOHoronchikLYedidiaY 2002 Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41 12868 12875
16. SafarJGGeschwindMDDeeringCDidorenkoSSattavatM 2005 Diagnosis of human prion disease. Proc Natl Acad Sci U S A 102 3501 3506
17. CaugheyBLansburyPT 2003 Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26 267 298
18. SilveiraJRRaymondGJHughsonAGRaceRESimVL 2005 The most infectious prion protein particles. Nature 437 257 261
19. PastranaMASajnaniGOniskoBCastillaJMoralesR 2006 Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 45 15710 15717
20. SilvaCJOniskoBCDyninIEricksonMLRequenaJR 2011 Utility of Mass Spectrometry in the Diagnosis of Prion Diseases. Anal Chem 83 1609 1615
21. OniskoBCSilvaCJDyninIEricksonMVenselWH 2007 Sensitive, preclinical detection of prions in brain by nanospray liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 21 4023 4026
22. PrusinerSBCochranSPGrothDFDowneyDEBowmanKA 1982 Measurement of the scrapie agent using an incubation time interval assay. Ann Neurol 11 353 358
23. BessenRAMarshRF 1992 Identification of two biologically distinct strains of transmissible mink encephalopathy in hamsters. J Gen Virol 73 329 334
24. PrusinerSBMcKinleyMPGrothDFBowmanKAMockNI 1981 Scrapie agent contains a hydrophobic protein. Proc Natl Acad Sci U S A 78 6675 6679
25. PrusinerSBCochranSPAlpersMP 1985 Transmission of scrapie in hamsters. J Infect Dis 152 971 978
26. KimberlinRHWalkerCA 1986 Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol 67 Pt 2 255 263
27. SajnaniGPastranaMADyninIOniskoBRequenaJR 2008 Scrapie prion protein structural constraints obtained by limited proteolysis and mass spectrometry. J Mol Biol 382 88 98
28. WuJGageDAWatsonJT 1996 A strategy to locate cysteine residues in proteins by specific chemical cleavage followed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Anal Biochem 235 161 174
29. KimberlinRHWalkerC 1977 Characteristics of a short incubation model of scrapie in the golden hamster. J Gen Virol 34 295 304
30. BessenRAMarshRF 1994 Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68 7859 7868
31. BarronRMCampbellSLKingDBellonAChapmanKE 2007 High titers of transmissible spongiform encephalopathy infectivity associated with extremely low levels of PrPSc in vivo. J Biol Chem 282 35878 35886
32. LasmezasCIDeslysJPRobainOJaeglyABeringueV 1997 Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science 275 402 405
33. MansonJC 1999 Understanding transmission of the prion diseases. Trends Microbiol 7 465 467
34. RaceRMeade-WhiteKRainesARaymondGJCaugheyB 2002 Subclinical scrapie infection in a resistant species: persistence, replication, and adaptation of infectivity during four passages. J Infect Dis 186 Suppl 2 S166 170
35. TremblayPBallHLKanekoKGrothDHegdeRS 2004 Mutant PrPSc conformers induced by a synthetic peptide and several prion strains. J Virol 78 2088 2099
36. WeberPReznicekLMittereggerGKretzschmarHGieseA 2008 Differential effects of prion particle size on infectivity in vivo and in vitro. Biochem Biophys Res Commun 369 924 928
37. MaselJJansenVA 2001 The measured level of prion infectivity varies in a predictable way according to the aggregation state of the infectious agent. Biochim Biophys Acta 1535 164 173
38. CronierSGrosNTattumMHJacksonGSClarkeAR 2008 Detection and characterization of proteinase K-sensitive disease-related prion protein with thermolysin. Biochem J 416 297 305
39. WeberPGieseAPieningNMittereggerGThomzigA 2007 Generation of genuine prion infectivity by serial PMCA. Vet Microbiol 123 346 357
40. McKinleyMPBraunfeldMBBellingerCGPrusinerSB 1986 Molecular characteristics of prion rods purified from scrapie-infected hamster brains. J Infect Dis 154 110 120
41. GabizonRMcKinleyMPPrusinerSB 1988 Properties of scrapie prion proteins in liposomes and amyloid rods. Ciba Found Symp 135 182 196
42. DeleaultAMDeleaultNRHarrisBTReesJRSupattaponeS 2008 The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie. J Gen Virol 89 2642 2650
43. DiringerHBeekesMOzelMSimonDQueckI 1997 Highly infectious purified preparations of disease-specific amyloid of transmissible spongiform encephalopathies are not devoid of nucleic acids of viral size. Intervirology 40 238 246
44. BoltonDCRudelliRDCurrieJRBendheimPE 1991 Copurification of Sp33–37 and scrapie agent from hamster brain prior to detectable histopathology and clinical disease. J Gen Virol 72 2905 2913
45. PrusinerSBGrothDSerbanAStahlNGabizonR 1993 Attempts to restore scrapie prion infectivity after exposure to protein denaturants. Proc Natl Acad Sci U S A 90 2793 2797
46. BruceMEMcConnellIFraserHDickinsonAG 1991 The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol 72 Pt 3 595 603
47. FraserHDickinsonAG 1968 The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol 78 301 311
48. SchaggerH 2006 Tricine-SDS-PAGE. Nat Protoc 1 16 22
Štítky
Hygiena a epidemiológia Infekčné lekárstvo LaboratóriumČlánok vyšiel v časopise
PLOS Pathogens
2012 Číslo 3
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Koronavirus hýbe světem: Víte jak se chránit a jak postupovat v případě podezření?
Najčítanejšie v tomto čísle
- A Foot in the Door for Dermatophyte Research
- An Entomopathogenic Nematode by Any Other Name
- New Insights into spp.: A Potential Link with Irritable Bowel Syndrome
- Short ORF-Dependent Ribosome Shunting Operates in an RNA Picorna-Like Virus and a DNA Pararetrovirus that Cause Rice Tungro Disease